The increasing trend of inhaling 5meo dimethyltryptamine in Canada presents considerable risks and complex juridical concerns. Currently, 5meo copyright remains a Class Number One substance within the CDSA, rendering its possession and distribution illegal. While inhalation delivers the chemical rapidly, it also introduces new health dangers connec